In new study, UMass Chan scientists induce toxicity to kill cancer cells
Dohoon Kim, PhD, and colleagues have shown that blocking a specific detoxifying enzyme in lung cancer cells leads to cell death, making it a viable target for drug development.
Read more
, School of Medicine, Cancer Center, Research, Dohoon Kim, Molecular, Cell and Cancer Biology, Latest News, BRIDGE, Top Stories,
UMass Chan BRIDGE Fund invests nearly $2M in 13 faculty projects
The BRIDGE Fund supports critical research milestones for inventions and discoveries that have high potential to change the course of disease and continues to grow, increasing from approximately $1 million per year in 2019 to $3 million in 2024.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Dermatology, Medicine, Cancer Center, Faculty, Award, Research, Craig Ceol, Dohoon Kim, Paul R. Thompson, Sontheimer Lab, Harris Lab, John Harris, Molecular, Cell and Cancer Biology, RNA Therapeutics Institute, Microbiology and Physiological Systems, Program in Molecular Medicine, Celia Schiffer, Schiffer Lab, Latest News, Andrei Korostelev, Biochemistry and Molecular Biotechnology, Erik Sontheimer, BRIDGE, Top Stories, Fiachra Humphries,
Dohoon Kim receives $2 million Young Investigator Award from Suh Kyungbae Science Foundation
Dohoon Kim, PhD, was named a 2017 Suh Kyungbae Science Foundation Young Investigator Award recipient. The accompanying $2 million, five-year grant will support research into changes in metabolic pathways that support cancer cells.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Cancer Center, Faculty, Dohoon Kim, Molecular, Cell and Cancer Biology,